LOSARTAN

LOSARTAN was reported 177626 times

LOSARTAN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CARDIOSPASM 343 0.6147
1 IMMUNISATION 222 0.5115
2 PALMOPLANTAR KERATODERMA 337 0.4648
3 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 185 0.1742
4 ATRIAL TACHYCARDIA 352 0.1675
5 PRURITUS GENITAL 382 0.1621
6 HYPERPARATHYROIDISM SECONDARY 364 0.1451
7 NEPHROGENIC ANAEMIA 651 0.1404
8 CAROTID ARTERY OCCLUSION 411 0.1125
9 REBOUND ACID HYPERSECRETION 339 0.1120
10 BRASH SYNDROME 148 0.1054
11 TENSION HEADACHE 412 0.0957
12 SLEEP TERROR 363 0.0861
13 MULTI-ORGAN DISORDER 147 0.0747
14 END STAGE RENAL DISEASE 1265 0.0693
15 ESSENTIAL HYPERTENSION 102 0.0557
16 CHRONIC KIDNEY DISEASE 4198 0.0552
17 FACIAL PAIN 461 0.0516
18 DENGUE FEVER 117 0.0510
19 EYELID PAIN 101 0.0497
20 DISCOURAGEMENT 105 0.0449
21 GASTROINTESTINAL HYPOMOTILITY 97 0.0430
22 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 105 0.0424
23 SUBARACHNOID HAEMORRHAGE 429 0.0421
24 ASTHMATIC CRISIS 153 0.0418
25 LOSS OF EMPLOYMENT 124 0.0410
26 VASCULITIS 460 0.0394
27 BLOOD PRESSURE INADEQUATELY CONTROLLED 223 0.0370
28 ANOSMIA 526 0.0363
29 BODY HEIGHT DECREASED 388 0.0362
30 BLOOD CHOLESTEROL ABNORMAL 157 0.0340
31 INFARCTION 227 0.0331
32 IMPAIRED GASTRIC EMPTYING 450 0.0330
33 DIABETIC NEUROPATHY 158 0.0319
34 RENAL INJURY 930 0.0313
35 BLOOD PRESSURE ABNORMAL 620 0.0312
36 ACUTE KIDNEY INJURY 4768 0.0311
37 ARTERIAL OCCLUSIVE DISEASE 243 0.0309
38 VENTRICULAR TACHYCARDIA 506 0.0306
39 GLOMERULAR FILTRATION RATE DECREASED 375 0.0305
40 EYE HAEMORRHAGE 404 0.0302
41 OLIGOHYDRAMNIOS 100 0.0300
42 HYPERTENSIVE CRISIS 326 0.0293
43 HAIR DISORDER 240 0.0291
44 SUSPECTED SUICIDE 134 0.0286
45 TUBULOINTERSTITIAL NEPHRITIS 534 0.0285
46 BLOOD PRESSURE INCREASED 4319 0.0282
47 HAEMORRHAGIC ANAEMIA 124 0.0282
48 THYROID MASS 107 0.0279
49 BLOOD MAGNESIUM DECREASED 238 0.0275
50 HAIR COLOUR CHANGES 342 0.0275
51 SPINAL PAIN 318 0.0271
52 HYPERKALAEMIA 950 0.0271
53 THYROID DISORDER 417 0.0270
54 GLUCOSE TOLERANCE IMPAIRED 159 0.0269
55 VARICOSE VEIN 138 0.0267
56 DIZZINESS POSTURAL 258 0.0266
57 VITAMIN D DEFICIENCY 259 0.0265
58 HYPERKERATOSIS 146 0.0264
59 SEASONAL ALLERGY 373 0.0263
60 PERIPHERAL SWELLING 4031 0.0261
61 YELLOW SKIN 121 0.0258
62 FOREIGN BODY SENSATION IN EYES 164 0.0257
63 DIPLOPIA 668 0.0257
64 TRANSIENT ISCHAEMIC ATTACK 866 0.0256
65 HEPATIC STEATOSIS 473 0.0254
66 BLOOD PRESSURE FLUCTUATION 608 0.0253
67 DIVERTICULUM INTESTINAL 110 0.0251
68 GOUT 450 0.0251
69 CHOKING SENSATION 137 0.0248
70 PERICARDITIS 416 0.0247
71 FEELING OF DESPAIR 115 0.0246
72 MENISCUS INJURY 151 0.0245
73 HAEMOGLOBIN INCREASED 112 0.0245
74 EYE PRURITUS 824 0.0245
75 SPINAL STENOSIS 101 0.0244
76 ATRIOVENTRICULAR BLOCK FIRST DEGREE 106 0.0244
77 PSYCHOLOGICAL TRAUMA 211 0.0244
78 NEPHROPATHY 228 0.0244
79 TONGUE DISCOMFORT 103 0.0242
80 OCULAR DISCOMFORT 272 0.0242
81 CORONARY ARTERY OCCLUSION 330 0.0240
82 UPPER-AIRWAY COUGH SYNDROME 198 0.0240
83 MOUTH SWELLING 138 0.0239
84 EYE PAIN 1348 0.0239
85 PRE-EXISTING CONDITION IMPROVED 149 0.0238
86 HAIR TEXTURE ABNORMAL 319 0.0238
87 LIP SWELLING 793 0.0238
88 BLOOD POTASSIUM DECREASED 715 0.0238
89 MUSCLE TWITCHING 546 0.0237
90 HYPERTENSION 4985 0.0235
91 MALNUTRITION 263 0.0235
92 ANGIOEDEMA 1026 0.0232
93 INTERVERTEBRAL DISC DISORDER 99 0.0232
94 INCREASED TENDENCY TO BRUISE 213 0.0231
95 RENAL FAILURE 3072 0.0231
96 BLOOD SODIUM DECREASED 436 0.0231
97 RENAL PAIN 245 0.0231
98 ANGINA UNSTABLE 150 0.0231
99 OSTEOARTHRITIS 978 0.0230
100 LOWER GASTROINTESTINAL HAEMORRHAGE 170 0.0230
101 NERVE COMPRESSION 212 0.0229
102 ANAL INCONTINENCE 206 0.0229
103 NOCTURIA 277 0.0228
104 SLEEP APNOEA SYNDROME 434 0.0227
105 ORAL PAIN 506 0.0226
106 PRODUCT ADMINISTRATION INTERRUPTED 177 0.0225
107 TASTE DISORDER 457 0.0225
108 PROSTATIC SPECIFIC ANTIGEN INCREASED 310 0.0225
109 MADAROSIS 260 0.0224
110 PRODUCT SUPPLY ISSUE 158 0.0221
111 PROTEIN URINE PRESENT 110 0.0220
112 IMMUNODEFICIENCY 326 0.0218
113 RHINITIS ALLERGIC 97 0.0218
114 BLOOD POTASSIUM INCREASED 353 0.0217
115 TINNITUS 998 0.0217
116 SPINAL DISORDER 203 0.0214
117 PLATELET COUNT INCREASED 279 0.0214
118 SKIN ATROPHY 123 0.0214
119 ONYCHOCLASIS 147 0.0213
120 CATARACT 1272 0.0213
121 POSTOPERATIVE WOUND INFECTION 144 0.0213
122 AGEUSIA 528 0.0211
123 RENAL TUBULAR NECROSIS 207 0.0211
124 PRODUCT RESIDUE PRESENT 113 0.0209
125 ACUTE MYOCARDIAL INFARCTION 616 0.0209
126 COUGH 5853 0.0208
127 HIATUS HERNIA 270 0.0208
128 HYPOMAGNESAEMIA 290 0.0208
129 EYE INFECTION 235 0.0208
130 DECREASED IMMUNE RESPONSIVENESS 204 0.0208
131 POLYP 136 0.0208
132 RHINITIS 167 0.0207
133 DRY THROAT 210 0.0206
134 DYSPHONIA 1200 0.0205
135 BLOOD IRON DECREASED 243 0.0205
136 OVERWEIGHT 110 0.0205
137 BLINDNESS 834 0.0204
138 HEAD DISCOMFORT 362 0.0204
139 MULTIPLE ALLERGIES 160 0.0204
140 PULMONARY MASS 304 0.0204
141 RASH PAPULAR 457 0.0204
142 GROIN PAIN 179 0.0204
143 POLLAKIURIA 850 0.0204
144 DECREASED ACTIVITY 218 0.0202
145 CARDIOMEGALY 248 0.0201
146 PAIN OF SKIN 541 0.0201
147 FULL BLOOD COUNT DECREASED 403 0.0200
148 GASTROOESOPHAGEAL REFLUX DISEASE 1606 0.0199
149 CARDIAC VALVE DISEASE 114 0.0199
150 DYSSTASIA 582 0.0199
151 MOUTH HAEMORRHAGE 146 0.0199
152 RENAL CYST 158 0.0199
153 CARDIAC FLUTTER 128 0.0198
154 BRAIN FOG 310 0.0198
155 HAEMORRHAGIC STROKE 154 0.0197
156 PULMONARY OEDEMA 882 0.0197
157 ANEURYSM 98 0.0197
158 SPRUE-LIKE ENTEROPATHY 97 0.0197
159 HYPOVOLAEMIA 115 0.0196
160 PROTEINURIA 373 0.0196
161 URINARY TRACT INFECTION 3345 0.0196
162 PRODUCTIVE COUGH 936 0.0196
163 DYSPNOEA EXERTIONAL 734 0.0195
164 GLAUCOMA 374 0.0194
165 INTERVERTEBRAL DISC DEGENERATION 179 0.0193
166 EYE DISCHARGE 201 0.0193
167 LIMB INJURY 525 0.0193
168 SKIN DISCOLOURATION 883 0.0192
169 VITAMIN D DECREASED 164 0.0192
170 ATRIAL FIBRILLATION 1867 0.0192
171 EXOSTOSIS 175 0.0191
172 GAIT INABILITY 640 0.0191
173 ATRIOVENTRICULAR BLOCK 148 0.0191
174 GASTRITIS 503 0.0191
175 BLINDNESS UNILATERAL 269 0.0191
176 HYPONATRAEMIA 1074 0.0190
177 PERIPHERAL VASCULAR DISORDER 98 0.0190
178 BLOOD CREATININE INCREASED 1241 0.0190
179 SCIATICA 303 0.0190
180 ROTATOR CUFF SYNDROME 244 0.0190
181 EAR DISCOMFORT 195 0.0190
182 BRONCHIECTASIS 128 0.0190
183 BLOOD GLUCOSE FLUCTUATION 208 0.0190
184 BLOOD URINE PRESENT 360 0.0189
185 LACTIC ACIDOSIS 614 0.0189
186 CONCOMITANT DISEASE AGGRAVATED 117 0.0189
187 CARDIAC PACEMAKER INSERTION 113 0.0189
188 SWELLING OF EYELID 119 0.0189
189 LARGE INTESTINE POLYP 131 0.0189
190 URINE OUTPUT DECREASED 165 0.0189
191 RENAL DISORDER 877 0.0188
192 LIGAMENT SPRAIN 186 0.0188
193 MUSCULAR WEAKNESS 2129 0.0187
194 SLUGGISHNESS 191 0.0187
195 POLYURIA 153 0.0187
196 ATRIAL FLUTTER 149 0.0187
197 EATING DISORDER 397 0.0186
198 HEART RATE DECREASED 652 0.0185
199 CARPAL TUNNEL SYNDROME 260 0.0185
200 UPPER GASTROINTESTINAL HAEMORRHAGE 312 0.0185
201 SINUS DISORDER 367 0.0185
202 ARTHRITIS 1451 0.0184
203 VITREOUS FLOATERS 181 0.0184
204 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 189 0.0184
205 OROPHARYNGEAL DISCOMFORT 166 0.0184
206 URINE ODOUR ABNORMAL 108 0.0183
207 PLATELET COUNT ABNORMAL 111 0.0183
208 PERICARDIAL EFFUSION 424 0.0183
209 LACRIMATION INCREASED 554 0.0183
210 GAIT DISTURBANCE 3502 0.0183
211 COVID-19 3209 0.0183
212 SECRETION DISCHARGE 229 0.0183
213 HALLUCINATION 1374 0.0182
214 BALANCE DISORDER 1575 0.0182
215 BURSITIS 221 0.0182
216 SPINAL OSTEOARTHRITIS 160 0.0182
217 FEEDING DISORDER 369 0.0182
218 BACK PAIN 4226 0.0182
219 RED BLOOD CELL COUNT DECREASED 520 0.0182
220 ORTHOSTATIC HYPOTENSION 316 0.0181
221 EYE IRRITATION 1044 0.0181
222 INTENTIONAL DOSE OMISSION 517 0.0181
223 FAECES DISCOLOURED 393 0.0181
224 ABDOMINAL DISCOMFORT 3035 0.0181
225 IRON DEFICIENCY ANAEMIA 167 0.0181
226 BASAL CELL CARCINOMA 282 0.0181
227 BLOOD PRESSURE DECREASED 1199 0.0180
228 ASPHYXIA 147 0.0180
229 FLUID RETENTION 915 0.0180
230 CONSTIPATION 3913 0.0179
231 LIMB DISCOMFORT 555 0.0179
232 PRODUCT TASTE ABNORMAL 242 0.0179
233 DRY MOUTH 1449 0.0178
234 APHONIA 249 0.0178
235 MUSCULOSKELETAL DISCOMFORT 307 0.0178
236 CHEST PAIN 3299 0.0178
237 IMPAIRED QUALITY OF LIFE 256 0.0178
238 INFUSION SITE SWELLING 112 0.0178
239 DEHYDRATION 2372 0.0178
240 LEFT VENTRICULAR DYSFUNCTION 119 0.0177
241 BOWEL MOVEMENT IRREGULARITY 136 0.0177
242 ABNORMAL LOSS OF WEIGHT 121 0.0177
243 INTERVERTEBRAL DISC PROTRUSION 388 0.0177
244 MEMORY IMPAIRMENT 2434 0.0177
245 CONTRAINDICATED PRODUCT ADMINISTERED 535 0.0177
246 DIABETES MELLITUS 1346 0.0176
247 VISUAL IMPAIRMENT 2181 0.0176
248 PROSTATIC DISORDER 97 0.0176
249 FLATULENCE 996 0.0175
250 ABDOMINAL PAIN UPPER 3609 0.0175
251 HOT FLUSH 1320 0.0175
252 JOINT INJURY 372 0.0174
253 NASAL DRYNESS 109 0.0174
254 HEART RATE IRREGULAR 393 0.0174
255 MUSCULOSKELETAL CHEST PAIN 269 0.0174
256 ACUTE RESPIRATORY FAILURE 334 0.0173
257 PRODUCT DISTRIBUTION ISSUE 161 0.0173
258 BLINDNESS TRANSIENT 128 0.0173
259 AMNESIA 1129 0.0173
260 EPISTAXIS 1298 0.0173
261 SNEEZING 389 0.0173
262 INFLUENZA 1931 0.0173
263 HOSPICE CARE 171 0.0173
264 WEIGHT FLUCTUATION 181 0.0173
265 WEIGHT DECREASED 4825 0.0173
266 URINARY INCONTINENCE 512 0.0173
267 BRONCHITIS 1279 0.0173
268 DIZZINESS 8618 0.0173
269 MYOPATHY 149 0.0172
270 PULMONARY THROMBOSIS 188 0.0172
271 RHINORRHOEA 1114 0.0172
272 HEART RATE INCREASED 1705 0.0172
273 CATARACT OPERATION 102 0.0172
274 CHOKING 335 0.0172
275 RENAL IMPAIRMENT 1439 0.0171
276 BLOOD CHOLESTEROL INCREASED 798 0.0171
277 BACK DISORDER 278 0.0171
278 SKIN FISSURES 333 0.0170
279 DECREASED APPETITE 3954 0.0170
280 DRY EYE 848 0.0170
281 HYPERGLYCAEMIA 619 0.0170
282 FOOT DEFORMITY 188 0.0169
283 PAIN IN EXTREMITY 4997 0.0169
284 THIRST 303 0.0169
285 ARTERIOSCLEROSIS CORONARY ARTERY 112 0.0169
286 OSTEOPENIA 256 0.0169
287 NODULE 220 0.0168
288 PRODUCT DOSE OMISSION IN ERROR 477 0.0168
289 MUSCLE SPASMS 3081 0.0168
290 HYPOPHAGIA 429 0.0168
291 DIVERTICULITIS 465 0.0168
292 FAECES SOFT 122 0.0168
293 MUSCLE STRAIN 145 0.0167
294 EXTRASYSTOLES 117 0.0167
295 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 874 0.0167
296 PHOTOPHOBIA 315 0.0167
297 CONTUSION 1612 0.0167
298 INTERNAL HAEMORRHAGE 191 0.0167
299 FALL 5559 0.0167
300 CARDIAC FAILURE CONGESTIVE 1341 0.0167
301 NAIL DISORDER 146 0.0167
302 PIGMENTATION DISORDER 103 0.0167
303 CONCUSSION 129 0.0166
304 INCONTINENCE 176 0.0166
305 RETINAL DETACHMENT 153 0.0166
306 BLOOD PRESSURE SYSTOLIC INCREASED 324 0.0166
307 PALPITATIONS 1943 0.0166
308 SCRATCH 175 0.0166
309 DYSURIA 610 0.0166
310 DEFAECATION URGENCY 116 0.0165
311 DIARRHOEA 10679 0.0165
312 PRODUCT AVAILABILITY ISSUE 376 0.0165
313 KIDNEY INFECTION 324 0.0165
314 SPINAL OPERATION 203 0.0165
315 POST PROCEDURAL INFECTION 134 0.0165
316 GINGIVAL BLEEDING 225 0.0165
317 SPLENOMEGALY 193 0.0165
318 ARTERIOSCLEROSIS 155 0.0165
319 HEAD INJURY 521 0.0164
320 RETCHING 351 0.0164
321 ASTHENIA 6190 0.0164
322 TOOTH FRACTURE 181 0.0164
323 FATIGUE 12774 0.0164
324 PETECHIAE 171 0.0164
325 WALKING AID USER 108 0.0164
326 PHARYNGEAL SWELLING 160 0.0163
327 MUSCLE ATROPHY 207 0.0163
328 DIABETES MELLITUS INADEQUATE CONTROL 289 0.0163
329 HAEMOGLOBIN ABNORMAL 105 0.0163
330 ARTHRALGIA 6762 0.0162
331 DYSPEPSIA 1600 0.0162
332 SKIN HAEMORRHAGE 241 0.0162
333 COGNITIVE DISORDER 759 0.0162
334 DISEASE RECURRENCE 773 0.0162
335 PERIPHERAL COLDNESS 223 0.0162
336 ORAL DISORDER 119 0.0162
337 BREAST MASS 109 0.0162
338 FEELING COLD 451 0.0162
339 NEPHROLITHIASIS 743 0.0162
340 THROAT IRRITATION 726 0.0162
341 FULL BLOOD COUNT ABNORMAL 171 0.0162
342 HYPOTENSION 3243 0.0161
343 GLYCOSYLATED HAEMOGLOBIN INCREASED 408 0.0161
344 MACULAR DEGENERATION 193 0.0161
345 EAR PAIN 314 0.0161
346 HYPERLIPIDAEMIA 193 0.0161
347 INSURANCE ISSUE 246 0.0161
348 TENDON RUPTURE 198 0.0160
349 MICTURITION URGENCY 183 0.0160
350 TENDONITIS 248 0.0160
351 POST PROCEDURAL HAEMORRHAGE 186 0.0160
352 NEURALGIA 388 0.0159
353 DYSPNOEA 9031 0.0159
354 NASAL CONGESTION 937 0.0159
355 RECALLED PRODUCT ADMINISTERED 152 0.0159
356 CYSTITIS 507 0.0159
357 PAPULE 112 0.0159
358 HAEMORRHOIDS 309 0.0158
359 NEUROPATHY PERIPHERAL 1506 0.0158
360 BONE PAIN 926 0.0158
361 DIVERTICULUM 112 0.0157
362 NECK PAIN 880 0.0157
363 SKIN ULCER 407 0.0157
364 HYPOGLYCAEMIA 763 0.0157
365 HICCUPS 129 0.0157
366 PHOTOPSIA 99 0.0156
367 BLOOD UREA INCREASED 262 0.0156
368 GASTROINTESTINAL INFECTION 140 0.0156
369 INTENTIONAL PRODUCT MISUSE 1367 0.0156
370 FACIAL PARALYSIS 133 0.0156
371 SYNCOPE 1560 0.0156
372 GASTROINTESTINAL HAEMORRHAGE 1302 0.0156
373 BLOOD TRIGLYCERIDES INCREASED 275 0.0155
374 SOMNAMBULISM 102 0.0155
375 AORTIC ANEURYSM 118 0.0155
376 ERUCTATION 300 0.0155
377 COVID-19 PNEUMONIA 183 0.0155
378 DYSGEUSIA 1148 0.0154
379 SCAB 176 0.0154
380 EYE INFLAMMATION 147 0.0154
381 PRODUCT SUBSTITUTION ISSUE 886 0.0154
382 HAND FRACTURE 109 0.0154
383 POOR QUALITY SLEEP 331 0.0154
384 CHOLELITHIASIS 504 0.0154
385 JOINT SWELLING 1853 0.0153
386 OROPHARYNGEAL PAIN 1419 0.0153
387 GINGIVAL PAIN 122 0.0153
388 WOUND 428 0.0153
389 MASS 214 0.0153
390 FEELING ABNORMAL 3662 0.0153
391 HAEMATURIA 522 0.0152
392 NERVE INJURY 169 0.0152
393 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 258 0.0152
394 BLOOD GLUCOSE INCREASED 2860 0.0152
395 CARDIAC FAILURE ACUTE 101 0.0151
396 CHROMATURIA 342 0.0151
397 CARDIAC MURMUR 131 0.0151
398 MYALGIA 2573 0.0151
399 HAEMOGLOBIN DECREASED 1553 0.0151
400 TOOTH INFECTION 199 0.0151
401 THERAPY INTERRUPTED 1077 0.0151
402 SWELLING 1410 0.0151
403 RESPIRATORY TRACT CONGESTION 239 0.0150
404 LYMPHOEDEMA 104 0.0150
405 TOOTH DISORDER 334 0.0150
406 ISCHAEMIC STROKE 268 0.0150
407 STENT PLACEMENT 121 0.0150
408 BLADDER DISORDER 149 0.0150
409 ALOPECIA 2946 0.0150
410 DEPRESSED MOOD 793 0.0150
411 PRODUCT ODOUR ABNORMAL 157 0.0150
412 SQUAMOUS CELL CARCINOMA 141 0.0150
413 WHEEZING 888 0.0150
414 DRUG INTERACTION 2372 0.0149
415 HYPERHIDROSIS 1926 0.0149
416 JOINT DISLOCATION 158 0.0149
417 LOCALISED INFECTION 361 0.0149
418 GASTROINTESTINAL PAIN 164 0.0149
419 HYPERCALCAEMIA 184 0.0149
420 PELVIC FRACTURE 116 0.0149
421 BURNING SENSATION 1043 0.0149
422 SKIN MASS 99 0.0148
423 ORAL DISCOMFORT 206 0.0148
424 VISION BLURRED 2035 0.0148
425 INSOMNIA 3939 0.0148
426 HAEMATOMA 382 0.0147
427 HAIR GROWTH ABNORMAL 102 0.0147
428 ABDOMINAL DISTENSION 1538 0.0147
429 OSTEOPOROSIS 606 0.0147
430 NERVOUSNESS 769 0.0147
431 BLOOD COUNT ABNORMAL 223 0.0147
432 WOUND INFECTION 161 0.0147
433 SINUS BRADYCARDIA 142 0.0147
434 SINUSITIS 1504 0.0147
435 EJECTION FRACTION DECREASED 228 0.0147
436 ANGINA PECTORIS 420 0.0146
437 INITIAL INSOMNIA 150 0.0146
438 SKIN LESION 401 0.0146
439 FLANK PAIN 137 0.0146
440 TRANSFUSION 153 0.0146
441 OCULAR HYPERAEMIA 693 0.0146
442 SWOLLEN TONGUE 456 0.0146
443 EYE SWELLING 543 0.0146
444 DISTURBANCE IN ATTENTION 787 0.0146
445 MOBILITY DECREASED 1048 0.0146
446 RIB FRACTURE 300 0.0146
447 TOOTHACHE 264 0.0146
448 SINUS CONGESTION 197 0.0146
449 DEAFNESS 381 0.0146
450 HYPOKALAEMIA 671 0.0145
451 PLATELET COUNT DECREASED 1549 0.0145
452 RASH MACULAR 508 0.0145
453 STOMATITIS 881 0.0145
454 OXYGEN SATURATION DECREASED 815 0.0145
455 KNEE ARTHROPLASTY 305 0.0145
456 ARRHYTHMIA 686 0.0145
457 UPPER RESPIRATORY TRACT INFECTION 668 0.0144
458 BEDRIDDEN 190 0.0144
459 PULMONARY HYPERTENSION 301 0.0144
460 INJECTION SITE NODULE 159 0.0144
461 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 694 0.0144
462 SKIN LACERATION 157 0.0144
463 KNEE OPERATION 142 0.0144
464 GENERALISED OEDEMA 178 0.0144
465 SPINAL FRACTURE 288 0.0144
466 PSYCHIATRIC SYMPTOM 106 0.0143
467 HERNIA 277 0.0143
468 HAEMATOCRIT DECREASED 284 0.0143
469 UROSEPSIS 132 0.0143
470 FOOT FRACTURE 271 0.0143
471 ECCHYMOSIS 98 0.0143
472 HYPOACUSIS 615 0.0143
473 BLOOD GLUCOSE ABNORMAL 263 0.0142
474 MYASTHENIA GRAVIS 115 0.0142
475 THERAPY CHANGE 140 0.0142
476 MALAISE 6244 0.0142
477 EYE DISORDER 465 0.0141
478 CARDIAC FAILURE 1135 0.0141
479 INFUSION SITE PAIN 182 0.0141
480 INFUSION SITE ERYTHEMA 119 0.0141
481 SWELLING FACE 915 0.0140
482 RECTAL HAEMORRHAGE 603 0.0140
483 SLEEP DISORDER 989 0.0140
484 ILLNESS 1443 0.0140
485 INTENTIONAL PRODUCT USE ISSUE 1227 0.0140
486 PRURITUS 5361 0.0139
487 CARDIAC DISORDER 1305 0.0139
488 ANURIA 120 0.0139
489 MUSCULOSKELETAL PAIN 729 0.0139
490 INFLAMMATION 717 0.0139
491 VENTRICULAR EXTRASYSTOLES 144 0.0139
492 CELLULITIS 698 0.0138
493 UPPER LIMB FRACTURE 275 0.0138
494 RESTLESS LEGS SYNDROME 251 0.0138
495 THROMBOSIS 1110 0.0138
496 INCREASED APPETITE 263 0.0138
497 OEDEMA PERIPHERAL 1676 0.0137
498 BLISTER 772 0.0137
499 ANHEDONIA 361 0.0137
500 PNEUMONIA 4445 0.0137
501 JOINT RANGE OF MOTION DECREASED 184 0.0137
502 PANCREATITIS ACUTE 308 0.0137
503 COORDINATION ABNORMAL 191 0.0137
504 LABORATORY TEST ABNORMAL 404 0.0137
505 HEADACHE 8579 0.0137
506 TROPONIN INCREASED 104 0.0137
507 NEOPLASM 157 0.0136
508 RASH PRURITIC 736 0.0136
509 ANKLE FRACTURE 210 0.0136
510 MUSCULOSKELETAL DISORDER 258 0.0135
511 INTENTIONAL UNDERDOSE 99 0.0135
512 CHEST DISCOMFORT 1387 0.0135
513 PRODUCT DOSE OMISSION 883 0.0135
514 BLOOD TEST ABNORMAL 190 0.0135
515 ELECTROLYTE IMBALANCE 157 0.0135
516 ARTHROPOD BITE 100 0.0135
517 HYDRONEPHROSIS 101 0.0135
518 MOVEMENT DISORDER 433 0.0135
519 ACIDOSIS 103 0.0135
520 CYST 167 0.0134
521 HYPOKINESIA 195 0.0134
522 ABNORMAL FAECES 110 0.0134
523 PRODUCT DOSE OMISSION ISSUE 3944 0.0134
524 PRESYNCOPE 326 0.0134
525 SPUTUM DISCOLOURED 127 0.0134
526 HIP FRACTURE 429 0.0133
527 PULMONARY CONGESTION 175 0.0133
528 HYPOAESTHESIA 1986 0.0133
529 TOOTH ABSCESS 135 0.0132
530 MITRAL VALVE INCOMPETENCE 150 0.0132
531 PARAESTHESIA ORAL 191 0.0132
532 CONFUSIONAL STATE 2134 0.0132
533 SKIN CANCER 284 0.0132
534 THERAPY CESSATION 674 0.0131
535 BLOOD GLUCOSE DECREASED 630 0.0131
536 BLOOD CALCIUM INCREASED 115 0.0131
537 ANAEMIA 2497 0.0131
538 PRODUCT USE COMPLAINT 206 0.0131
539 TENDON PAIN 99 0.0131
540 DIARRHOEA HAEMORRHAGIC 122 0.0130
541 CARDIAC OPERATION 112 0.0130
542 ARTHROPATHY 724 0.0130
543 MUSCLE TIGHTNESS 211 0.0130
544 DRY SKIN 1738 0.0130
545 LUNG DISORDER 638 0.0130
546 HYPERSOMNIA 373 0.0130
547 ELECTROCARDIOGRAM ABNORMAL 102 0.0130
548 OEDEMA 705 0.0130
549 SPEECH DISORDER 681 0.0130
550 MUSCULOSKELETAL STIFFNESS 1137 0.0130
551 HAEMOPTYSIS 362 0.0130
552 ERECTILE DYSFUNCTION 333 0.0130
553 GASTRIC DISORDER 445 0.0130
554 WHITE BLOOD CELL COUNT INCREASED 497 0.0129
555 VIRAL INFECTION 431 0.0129
556 RESPIRATORY TRACT INFECTION 337 0.0129
557 TACHYCARDIA 1149 0.0129
558 HEPATIC CIRRHOSIS 243 0.0129
559 HAEMORRHAGE INTRACRANIAL 193 0.0129
560 NASAL DISCOMFORT 102 0.0129
561 BREAST PAIN 137 0.0128
562 LETHARGY 739 0.0128
563 MUSCLE DISORDER 104 0.0128
564 PRESCRIBED UNDERDOSE 256 0.0128
565 GALLBLADDER DISORDER 229 0.0128
566 ASTHMA 1449 0.0128
567 PRODUCT ADMINISTRATION ERROR 259 0.0128
568 FIBROMYALGIA 311 0.0128
569 FEELING HOT 782 0.0127
570 PAIN 7830 0.0127
571 GASTROENTERITIS VIRAL 230 0.0127
572 METASTASES TO LUNG 147 0.0127
573 PARAESTHESIA 2001 0.0127
574 VERTIGO 771 0.0126
575 SKIN DISORDER 421 0.0126
576 INTRAOCULAR PRESSURE INCREASED 161 0.0126
577 BRADYCARDIA 668 0.0126
578 TRICUSPID VALVE INCOMPETENCE 100 0.0126
579 JOINT STIFFNESS 329 0.0125
580 PSORIATIC ARTHROPATHY 509 0.0125
581 PLEURAL EFFUSION 763 0.0125
582 NAUSEA 9917 0.0125
583 DENTAL CARIES 138 0.0125
584 TENDERNESS 130 0.0125
585 MYOCARDIAL INFARCTION 2176 0.0125
586 NASOPHARYNGITIS 2297 0.0124
587 HERPES ZOSTER 715 0.0124
588 WEIGHT INCREASED 2786 0.0124
589 URINARY RETENTION 415 0.0124
590 EMPHYSEMA 125 0.0124
591 PAIN IN JAW 351 0.0124
592 TREMOR 2056 0.0124
593 FURUNCLE 98 0.0124
594 EAR INFECTION 329 0.0124
595 PRURITUS GENERALISED 267 0.0123
596 DISCOMFORT 753 0.0123
597 HEMIPARESIS 209 0.0123
598 SKIN SWELLING 107 0.0123
599 PSORIASIS 1606 0.0123
600 IMMUNE SYSTEM DISORDER 162 0.0123
601 PHOTOSENSITIVITY REACTION 203 0.0123
602 DERMATITIS CONTACT 140 0.0123
603 HYPOCALCAEMIA 232 0.0122
604 ANXIETY 3479 0.0122
605 ABASIA 302 0.0122
606 INTERNATIONAL NORMALISED RATIO INCREASED 348 0.0122
607 SKIN EXFOLIATION 1028 0.0122
608 BLOOD THYROID STIMULATING HORMONE INCREASED 112 0.0122
609 SENSORY DISTURBANCE 195 0.0121
610 CEREBROVASCULAR ACCIDENT 2057 0.0121
611 METABOLIC ACIDOSIS 388 0.0121
612 LOWER LIMB FRACTURE 233 0.0121
613 DYSPHAGIA 1151 0.0121
614 SARS-COV-2 TEST POSITIVE 160 0.0121
615 TEMPERATURE INTOLERANCE 125 0.0121
616 MIDDLE INSOMNIA 226 0.0121
617 MYOCLONUS 144 0.0121
618 MALIGNANT MELANOMA 161 0.0120
619 WHITE BLOOD CELL COUNT DECREASED 1302 0.0120
620 PRODUCT PRESCRIBING ERROR 286 0.0120
621 LOSS OF CONSCIOUSNESS 1538 0.0120
622 COAGULOPATHY 200 0.0120
623 BLOOD DISORDER 96 0.0120
624 ACCIDENT 143 0.0120
625 VOMITING 5623 0.0119
626 CLOSTRIDIUM DIFFICILE INFECTION 261 0.0119
627 SMALL INTESTINAL OBSTRUCTION 147 0.0119
628 HYPOAESTHESIA ORAL 180 0.0119
629 NIGHTMARE 413 0.0119
630 BLOOD CALCIUM DECREASED 134 0.0119
631 HUNGER 166 0.0119
632 INABILITY TO AFFORD MEDICATION 118 0.0119
633 WRIST FRACTURE 142 0.0118
634 POST PROCEDURAL COMPLICATION 227 0.0118
635 HALLUCINATION, VISUAL 249 0.0118
636 CORONARY ARTERY DISEASE 357 0.0118
637 COMPLETED SUICIDE 982 0.0118
638 ABDOMINAL PAIN 2731 0.0117
639 DISORIENTATION 464 0.0117
640 CANDIDA INFECTION 197 0.0117
641 HEMIPLEGIA 97 0.0116
642 MIGRAINE 1111 0.0116
643 QUALITY OF LIFE DECREASED 156 0.0116
644 SKIN PLAQUE 98 0.0116
645 OBESITY 184 0.0115
646 PURPURA 102 0.0115
647 DERMATITIS ALLERGIC 145 0.0115
648 IMPAIRED DRIVING ABILITY 131 0.0115
649 BONE DISORDER 210 0.0115
650 DRUG-INDUCED LIVER INJURY 361 0.0115
651 NIGHT SWEATS 370 0.0115
652 FUNGAL INFECTION 382 0.0114
653 COLD SWEAT 202 0.0114
654 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2065 0.0114
655 CARDIO-RESPIRATORY ARREST 479 0.0114
656 PRODUCT PHYSICAL ISSUE 231 0.0114
657 HAEMATEMESIS 290 0.0114
658 CARDIOGENIC SHOCK 164 0.0114
659 HYPOTHYROIDISM 364 0.0114
660 SUBDURAL HAEMATOMA 163 0.0114
661 LEUKOCYTOSIS 206 0.0114
662 DEMENTIA 318 0.0114
663 SOMNOLENCE 2290 0.0114
664 DEPRESSION 2586 0.0114
665 BACTERIAL INFECTION 212 0.0114
666 IMPAIRED HEALING 373 0.0113
667 GLOSSODYNIA 254 0.0113
668 DELUSION 176 0.0113
669 PROCEDURAL PAIN 314 0.0113
670 THROAT TIGHTNESS 306 0.0113
671 GASTRIC ULCER 215 0.0113
672 RASH 4928 0.0113
673 HYPOXIA 398 0.0113
674 CHILLS 1323 0.0113
675 THERAPEUTIC RESPONSE UNEXPECTED 506 0.0113
676 LIVER DISORDER 500 0.0113
677 LACERATION 105 0.0112
678 SKIN INFECTION 125 0.0111
679 PALLOR 303 0.0111
680 DYSARTHRIA 419 0.0111
681 PHARYNGITIS 138 0.0111
682 PNEUMONIA BACTERIAL 102 0.0111
683 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 98 0.0111
684 DIABETIC KETOACIDOSIS 265 0.0110
685 CHOLECYSTECTOMY 126 0.0110
686 ECONOMIC PROBLEM 167 0.0110
687 HEPATOMEGALY 108 0.0110
688 INJECTION SITE DISCOLOURATION 137 0.0110
689 ORAL HERPES 214 0.0110
690 MELAENA 241 0.0109
691 BACK INJURY 119 0.0109
692 GASTROINTESTINAL DISORDER 977 0.0109
693 INTESTINAL OBSTRUCTION 411 0.0109
694 LUNG INFECTION 169 0.0109
695 PULMONARY FIBROSIS 208 0.0108
696 THERAPEUTIC PRODUCT EFFECT DECREASED 485 0.0108
697 GASTROENTERITIS 158 0.0108
698 FEAR 291 0.0108
699 COLON CANCER 161 0.0108
700 APHASIA 326 0.0108
701 SEPSIS 1203 0.0108
702 LOCAL SWELLING 188 0.0108
703 SURGERY 629 0.0107
704 METASTASES TO BONE 176 0.0107
705 MYOCARDIAL ISCHAEMIA 122 0.0107
706 COLITIS 404 0.0106
707 FLUID OVERLOAD 154 0.0106
708 RESPIRATORY DISORDER 316 0.0106
709 OESOPHAGITIS 115 0.0105
710 HIP ARTHROPLASTY 161 0.0105
711 DYSKINESIA 427 0.0105
712 CEREBRAL HAEMORRHAGE 376 0.0105
713 PARALYSIS 150 0.0105
714 HAEMATOCHEZIA 578 0.0105
715 ATELECTASIS 101 0.0104
716 TOOTH EXTRACTION 130 0.0104
717 EYELID PTOSIS 106 0.0104
718 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 241 0.0103
719 OBSTRUCTIVE AIRWAYS DISORDER 115 0.0103
720 PHARYNGEAL OEDEMA 159 0.0103
721 ORAL CANDIDIASIS 136 0.0103
722 RASH GENERALISED 267 0.0103
723 PYREXIA 3562 0.0103
724 TYPE 2 DIABETES MELLITUS 346 0.0103
725 RESPIRATORY FAILURE 748 0.0102
726 FREQUENT BOWEL MOVEMENTS 277 0.0102
727 HYPERSENSITIVITY 1902 0.0102
728 ULCER 163 0.0102
729 RHABDOMYOLYSIS 427 0.0102
730 THERAPY NON-RESPONDER 459 0.0102
731 MOTOR DYSFUNCTION 104 0.0102
732 GASTRIC HAEMORRHAGE 117 0.0102
733 OSTEOMYELITIS 184 0.0102
734 PNEUMOTHORAX 161 0.0101
735 MENTAL STATUS CHANGES 281 0.0101
736 PRODUCT DISPENSING ERROR 220 0.0101
737 CHOLECYSTITIS 120 0.0101
738 MOUTH ULCERATION 212 0.0101
739 RASH ERYTHEMATOUS 481 0.0101
740 INFECTION 1456 0.0100
741 HYPERCHOLESTEROLAEMIA 97 0.0100
742 CIRCULATORY COLLAPSE 171 0.0100
743 FEELING JITTERY 191 0.0100
744 INCORRECT PRODUCT ADMINISTRATION DURATION 217 0.0100
745 ROAD TRAFFIC ACCIDENT 416 0.0099
746 TREATMENT NONCOMPLIANCE 543 0.0099
747 IRRITABLE BOWEL SYNDROME 212 0.0099
748 BRONCHOSPASM 141 0.0099
749 APATHY 144 0.0099
750 VISUAL ACUITY REDUCED 326 0.0098
751 ADVERSE DRUG REACTION 881 0.0098
752 PNEUMONITIS 267 0.0098
753 UNEVALUABLE EVENT 741 0.0098
754 DRUG INTOLERANCE 942 0.0097
755 CARDIOMYOPATHY 143 0.0097
756 SCAR 165 0.0096
757 HEPATITIS 246 0.0096
758 INJECTION SITE MASS 354 0.0096
759 CONDITION AGGRAVATED 2909 0.0096
760 LIVER FUNCTION TEST INCREASED 205 0.0095
761 RHEUMATOID ARTHRITIS 1083 0.0095
762 ENCEPHALOPATHY 234 0.0095
763 DERMATITIS 199 0.0095
764 ILEUS 118 0.0095
765 UNRESPONSIVE TO STIMULI 245 0.0095
766 LYMPHADENOPATHY 336 0.0095
767 PRODUCT USE ISSUE 1773 0.0094
768 ABNORMAL DREAMS 260 0.0094
769 RED BLOOD CELL SEDIMENTATION RATE INCREASED 104 0.0094
770 HAEMORRHAGE 973 0.0093
771 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 662 0.0093
772 EXPIRED PRODUCT ADMINISTERED 309 0.0093
773 PANCREATITIS 490 0.0093
774 BLOOD ALKALINE PHOSPHATASE INCREASED 230 0.0093
775 CARDIAC ARREST 764 0.0092
776 DIALYSIS 131 0.0092
777 ERYTHEMA 1888 0.0092
778 FLUSHING 928 0.0091
779 TACHYPNOEA 124 0.0091
780 HEPATIC ENZYME INCREASED 621 0.0091
781 PRODUCT USE IN UNAPPROVED INDICATION 2248 0.0091
782 CONJUNCTIVITIS 168 0.0090
783 SEIZURE 1046 0.0090
784 PLASMA CELL MYELOMA 350 0.0090
785 THERAPEUTIC RESPONSE SHORTENED 297 0.0089
786 ANKYLOSING SPONDYLITIS 118 0.0089
787 PRODUCT PRESCRIBING ISSUE 195 0.0089
788 STAPHYLOCOCCAL INFECTION 295 0.0089
789 RESTLESSNESS 327 0.0089
790 OFF LABEL USE 7807 0.0089
791 RESPIRATORY DISTRESS 246 0.0089
792 CARDIOVASCULAR DISORDER 226 0.0089
793 ELECTROCARDIOGRAM QT PROLONGED 320 0.0089
794 RENAL FAILURE ACUTE 376 0.0089
795 INFLUENZA LIKE ILLNESS 729 0.0088
796 DEEP VEIN THROMBOSIS 572 0.0088
797 DERMATITIS ATOPIC 462 0.0088
798 FEMUR FRACTURE 271 0.0087
799 ABSCESS 139 0.0087
800 ACUTE HEPATIC FAILURE 119 0.0087
801 DEVICE RELATED INFECTION 134 0.0087
802 METASTASES TO LIVER 153 0.0087
803 BACTERAEMIA 103 0.0087
804 DRUG EFFECT LESS THAN EXPECTED 128 0.0086
805 LIVER FUNCTION TEST ABNORMAL 251 0.0086
806 DRUG DOSE OMISSION 1423 0.0086
807 ATAXIA 102 0.0086
808 CRYING 312 0.0086
809 UNDERDOSE 626 0.0086
810 NEOPLASM PROGRESSION 298 0.0086
811 URTICARIA 1432 0.0085
812 LYMPHOMA 132 0.0085
813 APPLICATION SITE PAIN 188 0.0085
814 ECZEMA 445 0.0085
815 CEREBRAL INFARCTION 205 0.0084
816 SKIN REACTION 118 0.0084
817 INJECTION SITE EXTRAVASATION 103 0.0083
818 CYANOSIS 131 0.0083
819 INJECTION SITE PRURITUS 558 0.0083
820 DRUG EFFECT INCOMPLETE 302 0.0083
821 PULMONARY EMBOLISM 790 0.0083
822 BODY TEMPERATURE INCREASED 168 0.0082
823 DEVICE DELIVERY SYSTEM ISSUE 225 0.0082
824 JAUNDICE 221 0.0082
825 THINKING ABNORMAL 153 0.0082
826 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1662 0.0082
827 DRUG PRESCRIBING ERROR 157 0.0082
828 MENTAL IMPAIRMENT 198 0.0082
829 ASPARTATE AMINOTRANSFERASE INCREASED 433 0.0081
830 PANIC ATTACK 297 0.0081
831 LYMPHOCYTE COUNT DECREASED 144 0.0081
832 PRODUCT QUALITY ISSUE 1106 0.0081
833 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 575 0.0081
834 LIVER INJURY 198 0.0081
835 AGITATION 592 0.0081
836 ACTIVITIES OF DAILY LIVING IMPAIRED 159 0.0080
837 APPLICATION SITE PRURITUS 182 0.0080
838 PRESCRIBED OVERDOSE 154 0.0080
839 MEDICATION ERROR 439 0.0079
840 ALANINE AMINOTRANSFERASE INCREASED 483 0.0079
841 NEEDLE ISSUE 229 0.0079
842 MOOD ALTERED 214 0.0078
843 SEPTIC SHOCK 335 0.0077
844 ABDOMINAL PAIN LOWER 194 0.0077
845 NEOPLASM MALIGNANT 510 0.0076
846 DELIRIUM 265 0.0076
847 DISEASE PROGRESSION 903 0.0076
848 SHOCK 174 0.0076
849 INCORRECT DOSE ADMINISTERED 1727 0.0076
850 EMOTIONAL DISORDER 232 0.0075
851 DRUG INEFFECTIVE 9903 0.0075
852 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 410 0.0075
853 INJECTION SITE BRUISING 596 0.0075
854 ILL-DEFINED DISORDER 452 0.0074
855 HOSPITALISATION 1138 0.0074
856 PULMONARY ARTERIAL HYPERTENSION 107 0.0074
857 THERAPY PARTIAL RESPONDER 115 0.0074
858 INJECTION SITE HAEMORRHAGE 588 0.0074
859 GENERAL PHYSICAL HEALTH DETERIORATION 844 0.0073
860 BLOOD BILIRUBIN INCREASED 196 0.0072
861 TOXIC EPIDERMAL NECROLYSIS 110 0.0072
862 HALLUCINATION, AUDITORY 115 0.0072
863 DEPRESSED LEVEL OF CONSCIOUSNESS 286 0.0072
864 ANGER 244 0.0072
865 BLOOD CREATINE PHOSPHOKINASE INCREASED 207 0.0072
866 NEUTROPHIL COUNT DECREASED 290 0.0071
867 HYPERTHYROIDISM 103 0.0071
868 INJECTION SITE RASH 216 0.0070
869 IMPAIRED WORK ABILITY 150 0.0070
870 LUNG NEOPLASM MALIGNANT 288 0.0070
871 DEVICE ISSUE 625 0.0070
872 RESPIRATORY ARREST 192 0.0070
873 MULTIPLE ORGAN DYSFUNCTION SYNDROME 197 0.0069
874 DRUG LEVEL INCREASED 115 0.0069
875 TOOTH LOSS 144 0.0069
876 DEVICE MALFUNCTION 486 0.0069
877 INJECTION SITE PAIN 2121 0.0069
878 APPLICATION SITE ERYTHEMA 180 0.0069
879 LOWER RESPIRATORY TRACT INFECTION 312 0.0069
880 TOXICITY TO VARIOUS AGENTS 1155 0.0068
881 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 117 0.0068
882 THERAPEUTIC RESPONSE DECREASED 413 0.0068
883 DRUG ERUPTION 120 0.0068
884 IRRITABILITY 407 0.0068
885 TRANSAMINASES INCREASED 149 0.0067
886 FACE OEDEMA 112 0.0066
887 ASCITES 195 0.0066
888 ACCIDENTAL OVERDOSE 241 0.0066
889 ADVERSE EVENT 604 0.0065
890 INFUSION RELATED REACTION 433 0.0065
891 SEROTONIN SYNDROME 125 0.0065
892 EXPOSURE VIA SKIN CONTACT 168 0.0065
893 WITHDRAWAL SYNDROME 272 0.0065
894 MULTIPLE SCLEROSIS RELAPSE 441 0.0064
895 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 165 0.0064
896 PARANOIA 110 0.0064
897 THROMBOCYTOPENIA 713 0.0064
898 SYSTEMIC LUPUS ERYTHEMATOSUS 226 0.0064
899 PNEUMONIA ASPIRATION 159 0.0064
900 DRUG EFFECT DECREASED 340 0.0063
901 INCORRECT DRUG ADMINISTRATION DURATION 176 0.0063
902 ANAPHYLACTIC REACTION 345 0.0062
903 DEVICE USE ISSUE 109 0.0062
904 INTERSTITIAL LUNG DISEASE 301 0.0062
905 ANAPHYLACTIC SHOCK 160 0.0062
906 INCORRECT DOSE ADMINISTERED BY DEVICE 160 0.0061
907 MENTAL DISORDER 264 0.0061
908 MALIGNANT NEOPLASM PROGRESSION 619 0.0060
909 EMOTIONAL DISTRESS 729 0.0060
910 ACUTE RESPIRATORY DISTRESS SYNDROME 106 0.0060
911 INJECTION SITE SWELLING 457 0.0060
912 DEVICE DEFECTIVE 103 0.0059
913 MULTIPLE SCLEROSIS 284 0.0059
914 FRACTURE 112 0.0059
915 MOOD SWINGS 188 0.0059
916 PELVIC PAIN 107 0.0059
917 EXTRA DOSE ADMINISTERED 238 0.0059
918 GAMMA-GLUTAMYLTRANSFERASE INCREASED 130 0.0059
919 INJECTION SITE URTICARIA 143 0.0058
920 INJECTION SITE ERYTHEMA 723 0.0058
921 ALTERED STATE OF CONSCIOUSNESS 126 0.0058
922 INJECTION SITE WARMTH 119 0.0058
923 DEATH 4980 0.0058
924 PANCYTOPENIA 321 0.0057
925 NERVOUS SYSTEM DISORDER 179 0.0057
926 DRUG ADMINISTRATION ERROR 176 0.0057
927 MUCOSAL INFLAMMATION 149 0.0057
928 PANCREATIC CARCINOMA 162 0.0056
929 PERITONITIS 116 0.0056
930 STEVENS-JOHNSON SYNDROME 123 0.0055
931 INTENTIONAL OVERDOSE 352 0.0055
932 PRODUCT PREPARATION ERROR 112 0.0054
933 WRONG TECHNIQUE IN DRUG USAGE PROCESS 197 0.0054
934 ABNORMAL BEHAVIOUR 210 0.0053
935 VAGINAL HAEMORRHAGE 229 0.0053
936 SUICIDAL IDEATION 483 0.0053
937 SKIN IRRITATION 239 0.0052
938 ACNE 393 0.0052
939 OSTEONECROSIS OF JAW 128 0.0052
940 COLITIS ULCERATIVE 229 0.0051
941 C-REACTIVE PROTEIN INCREASED 186 0.0051
942 DRUG RESISTANCE 131 0.0051
943 BONE DENSITY DECREASED 158 0.0050
944 DEVICE LEAKAGE 218 0.0050
945 NEUTROPENIA 678 0.0050
946 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 168 0.0050
947 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 230 0.0049
948 INJURY ASSOCIATED WITH DEVICE 100 0.0049
949 SEDATION 128 0.0049
950 AGGRESSION 244 0.0049
951 RASH MACULO-PAPULAR 108 0.0048
952 INJECTION SITE REACTION 334 0.0048
953 HEPATOTOXICITY 108 0.0048
954 COMA 220 0.0046
955 PRODUCT ADHESION ISSUE 165 0.0046
956 HEPATIC FAILURE 136 0.0045
957 ACCIDENTAL EXPOSURE TO PRODUCT 456 0.0044
958 BREAST CANCER 410 0.0044
959 SKIN BURNING SENSATION 314 0.0044
960 HEPATIC FUNCTION ABNORMAL 163 0.0044
961 NO ADVERSE EVENT 791 0.0044
962 FEBRILE NEUTROPENIA 287 0.0043
963 PSYCHOTIC DISORDER 124 0.0042
964 HEPATIC CANCER 100 0.0042
965 DRUG DOSE OMISSION BY DEVICE 319 0.0041
966 INJURY 282 0.0040
967 PRODUCT COMPLAINT 99 0.0039
968 LEUKOPENIA 192 0.0038
969 OSTEONECROSIS 124 0.0038
970 BREAST CANCER FEMALE 99 0.0037
971 PROSTATE CANCER 295 0.0037
972 PRODUCT STORAGE ERROR 319 0.0036
973 SUICIDE ATTEMPT 212 0.0035
974 EPILEPSY 105 0.0034
975 TREATMENT FAILURE 271 0.0033
976 INCORRECT ROUTE OF DRUG ADMINISTRATION 115 0.0032
977 DEVICE USE ERROR 111 0.0032
978 CONVULSION 182 0.0032
979 DEVICE BREAKAGE 129 0.0032
980 OVERDOSE 676 0.0031
981 DEVICE DISLOCATION 126 0.0029
982 RENAL CANCER 133 0.0028
983 BLADDER CANCER 149 0.0025
984 DEVICE DIFFICULT TO USE 167 0.0025
985 FOETAL EXPOSURE DURING PREGNANCY 182 0.0022
986 DRUG WITHDRAWAL SYNDROME 183 0.0021
987 EXPOSURE DURING PREGNANCY 123 0.0020
988 MATERNAL EXPOSURE DURING PREGNANCY 126 0.0014
989 DRUG ABUSE 115 0.0014
990 DRUG DEPENDENCE 192 0.0012